SIBO

IBS vs SIBO: Why Up to 78% of IBS Patients May Have Treatable Bacterial Overgrowth

SIBO is the single most common condition hiding behind an IBS diagnosis. An estimated 60 to 78 percent of IBS patients test positive for bacterial overgrowth on breath testing. Unlike IBS, SIBO has a specific cause, a specific test, and specific treatments that can resolve symptoms. If you have been told you have IBS and standard treatments are not working, SIBO should be at the top of your list.

Last updated 2026-04-25

Current Consensus

  • Multiple studies estimate that 60 to 78 percent of patients meeting Rome criteria for IBS test positive for SIBO on lactulose or glucose breath testing (Pimentel et al., 2000; Lin, 2004).
  • SIBO has identifiable causes including impaired migrating motor complex, structural abnormalities, and immunodeficiency, unlike IBS which is defined by symptom criteria alone.
  • Breath testing (lactulose or glucose) is the standard non-invasive diagnostic method, with the Trio-Smart test adding hydrogen sulfide measurement.
  • Antimicrobial treatment with rifaximin produces symptom improvement in approximately 64 percent of SIBO patients (Pimentel et al., 2011).
  • Post-infectious IBS can be objectively identified using anti-vinculin and anti-CdtB antibody testing (ibs-smart test).

Open Questions

  • Why some IBS patients test negative on breath testing but still respond to SIBO-targeted treatment.
  • The optimal breath test substrate (lactulose vs. glucose) and interpretation criteria for clinical diagnosis.
  • Whether SIBO is a primary condition or a downstream consequence of other motility and structural disorders.
  • Long-term recurrence rates after successful antimicrobial treatment and optimal prevention strategies.
  • The clinical significance of hydrogen sulfide SIBO, which was undetectable on older two-gas breath tests.

Not sure if this applies to you?

Our misdiagnosis quiz evaluates your symptoms against 14 conditions commonly confused with IBS.

Take the Quiz

Medical Disclaimer: The content in this section is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your health regimen. GLP1Gut is a tracking tool, not a medical device.